FDA schedules panel for Gattex

FDA's Gastrointestinal Drugs Advisory Committee will meet on Oct. 16 to discuss an NDA from NPS Pharmaceuticals Inc. (NASDAQ:NPSP) for Gattex teduglutide to treat short bowel syndrome (SBS). The PDUFA...